292 related articles for article (PubMed ID: 33759144)
21. Post-procedural myocardial infarction following surgical aortic valve replacement and transcatheter aortic valve implantation.
Dobson LE; Musa TA; Uddin A; Fairbairn TA; Swoboda PP; Ripley DP; Garg P; Evans B; Malkin CJ; Blackman DJ; Plein S; Greenwood JP
EuroIntervention; 2017 Jun; 13(2):e153-e160. PubMed ID: 28117280
[TBL] [Abstract][Full Text] [Related]
22. Microparticles in patients undergoing transcatheter aortic valve implantation (TAVI).
Jung C; Lichtenauer M; Figulla HR; Wernly B; Goebel B; Foerster M; Edlinger C; Lauten A
Heart Vessels; 2017 Apr; 32(4):458-466. PubMed ID: 27488119
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Early Stroke or Death in Patients Undergoing Transcatheter Aortic Valve Implantation.
Ricco JB; Castagnet H; Christiaens L; Palazzo P; Lamy M; Mergy J; Corbi P; Neau JP
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105912. PubMed ID: 34130105
[TBL] [Abstract][Full Text] [Related]
24. Urgent Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Acute Heart Failure: Procedural and 30-Day Outcomes.
Landes U; Orvin K; Codner P; Assali A; Vaknin-Assa H; Schwartznberg S; Levi A; Shapira Y; Sagie A; Kornowski R
Can J Cardiol; 2016 Jun; 32(6):726-31. PubMed ID: 26755244
[TBL] [Abstract][Full Text] [Related]
25. Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial.
Trejo-Velasco B; Cruz-González I; Tello-Montoliu A; Baz-Alonso JA; Salvadores PJ; Moreno R; Romaguera R; Molina-Navarro E; Paredes-Galán E; De-Miguel-Castro A; Bastos-Fernandez G; Ortiz-Saez A; Fernández-Barbeira S; Iñiguez-Romo A; Jimenez-Diaz VA
J Invasive Cardiol; 2020 Dec; 32(12):446-452. PubMed ID: 32771996
[TBL] [Abstract][Full Text] [Related]
26. Coagulation derangement and risk factors for valve thrombosis following transcatheter aortic valve implantation.
Patterson T; Hurrell H; Lee J; Esposito G; Dutta U; Grapsa J; Aroney N; Ahmed-Jushuf F; Allen C; Rajani R; Preston R; Young C; Lucchese G; Parmar K; Hunt B; Prendergast BD; Redwood SR
Open Heart; 2021 Jun; 8(1):. PubMed ID: 34127530
[TBL] [Abstract][Full Text] [Related]
27. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
28. Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Nijenhuis VJ; Bennaghmouch N; Hassell M; Baan J; van Kuijk JP; Agostoni P; van 't Hof A; Kievit PC; Veenstra L; van der Harst P; van den Heuvel AF; den Heijer P; Kelder JC; Deneer VH; van der Kley F; Onorati F; Collet JP; Maisano F; Latib A; Huber K; Stella PR; Ten Berg JM
Am Heart J; 2016 Mar; 173():77-85. PubMed ID: 26920599
[TBL] [Abstract][Full Text] [Related]
29. Impact of sigmoid septum on periprocedural outcomes following transcatheter aortic valve implantation using current-generation valves.
Tsuda M; Egami Y; Matsuhiro Y; Nakamura H; Yasumoto K; Okamoto N; Matsunaga-Lee Y; Yano M; Nishino M; Tanouchi J
Int J Cardiovasc Imaging; 2022 Jan; 38(1):171-180. PubMed ID: 34843040
[TBL] [Abstract][Full Text] [Related]
30. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
[TBL] [Abstract][Full Text] [Related]
31. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
32. The Value of the SYNTAX Score II in Predicting Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation.
Ryan N; Nombela-Franco L; Jiménez-Quevedo P; Biagioni C; Salinas P; Aldazábal A; Cerrato E; Gonzalo N; Del Trigo M; Núñez-Gil I; Fernández-Ortiz A; Macaya C; Escaned J
Rev Esp Cardiol (Engl Ed); 2018 Aug; 71(8):628-637. PubMed ID: 29191780
[TBL] [Abstract][Full Text] [Related]
33. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
[TBL] [Abstract][Full Text] [Related]
34. Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project.
Adamo M; Provini M; Fiorina C; Giannini C; Angelillis M; Testa L; Barbanti M; Merlanti B; Poli A; Ferrara E; Latib A; Reimers B; Maffeo D; Bruschi G; Montorfano M; Petronio AS; Bedogni F; Tamburino C; Metra M; Curello S
Catheter Cardiovasc Interv; 2020 Dec; 96(7):1500-1508. PubMed ID: 32644300
[TBL] [Abstract][Full Text] [Related]
35. Impact of Pre-procedural Cerebrovascular Events on Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis.
Wiktorowicz A; Kleczynski P; Dziewierz A; Tokarek T; Sorysz D; Bagienski M; Rzeszutko L; Dudek D
Curr Pharm Des; 2018; 24(5):641-646. PubMed ID: 29468958
[TBL] [Abstract][Full Text] [Related]
36. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
Bouleti C; Chauvet M; Franchineau G; Himbert D; Iung B; Alos B; Brochet E; Urena M; Ghodbane W; Ou P; Provenchere S; Nataf P; Vahanian A
Eur J Cardiothorac Surg; 2017 Jan; 51(1):80-88. PubMed ID: 27582074
[TBL] [Abstract][Full Text] [Related]
37. Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation: Influence of Pressure Overload on the Evaluation of Lesions Severity.
Pesarini G; Scarsini R; Zivelonghi C; Piccoli A; Gambaro A; Gottin L; Rossi A; Ferrero V; Vassanelli C; Ribichini F
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803040
[TBL] [Abstract][Full Text] [Related]
38. Left Atrial Phasic Function and Its Association With Atrial Fibrillation in Patients After Transcatheter Aortic Valve Implantation.
Poulin F; Thavendiranathan P; Carasso S; Rakowski H; Horlick EM; Osten MD; Cusimano RJ; Woo A
Can J Cardiol; 2017 Jul; 33(7):925-932. PubMed ID: 28668142
[TBL] [Abstract][Full Text] [Related]
39. Recovery of left ventricular mechanics after transcatheter aortic valve implantation: effects of baseline ventricular function and postprocedural aortic regurgitation.
Poulin F; Carasso S; Horlick EM; Rakowski H; Lim KD; Finn H; Feindel CM; Greutmann M; Osten MD; Cusimano RJ; Woo A
J Am Soc Echocardiogr; 2014 Nov; 27(11):1133-42. PubMed ID: 25125314
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
